212 related articles for article (PubMed ID: 37681872)
1. Stable Chinese Hamster Ovary Suspension Cell Lines Harboring Recombinant Human Cytochrome P450 Oxidoreductase and Human Cytochrome P450 Monooxygenases as Platform for In Vitro Biotransformation Studies.
Schulz C; Herzog N; Kubick S; Jung F; Küpper JH
Cells; 2023 Aug; 12(17):. PubMed ID: 37681872
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of mono Cytochrome P450 in a modified CHO-CPR cell-free protein production platform.
Knauer JF; Schulz C; Zemella A; Wüstenhagen DA; Walter RM; Küpper JH; Kubick S
Sci Rep; 2024 Jan; 14(1):1271. PubMed ID: 38218994
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of phase-1 biotransformation and cytostatic effects of diphenyleneiodonium on hepatoblastoma cell line HepG2 and a CYP3A4-overexpressing HepG2 cell clone.
Schulz C; Jung F; Küpper JH
Clin Hemorheol Microcirc; 2021; 79(1):231-243. PubMed ID: 34487034
[TBL] [Abstract][Full Text] [Related]
4. Human cytochrome P450 expression in bacteria: Whole-cell high-throughput activity assay for CYP1A2, 2A6 and 3A4.
Esteves F; Campelo D; Urban P; Bozonnet S; Lautier T; Rueff J; Truan G; Kranendonk M
Biochem Pharmacol; 2018 Dec; 158():134-140. PubMed ID: 30308189
[TBL] [Abstract][Full Text] [Related]
5. NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies.
Schulz C; Kammerer S; Küpper JH
Clin Hemorheol Microcirc; 2019; 73(1):249-260. PubMed ID: 31561354
[TBL] [Abstract][Full Text] [Related]
6. High levels of recombinant CYP3A4 expression in Chinese hamster ovary cells are modulated by coexpressed human P450 reductase and hemin supplementation.
Ding S; Yao D; Burchell B; Wolf CR; Friedberg T
Arch Biochem Biophys; 1997 Dec; 348(2):403-10. PubMed ID: 9434754
[TBL] [Abstract][Full Text] [Related]
7. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
8. Stable expression and coexpression of human cytochrome P450 oxidoreductase and cytochrome P450 1A2 in V79 Chinese hamster cells: sensitivity to quinones and biotransformation of 7-alkoxyresorufins and triazines.
Schmalix WA; Lang D; Schneider A; Bocker R; Greim H; Doehmer J
Drug Metab Dispos; 1996 Dec; 24(12):1314-9. PubMed ID: 8971136
[TBL] [Abstract][Full Text] [Related]
9. Probing the Role of the Hinge Segment of Cytochrome P450 Oxidoreductase in the Interaction with Cytochrome P450.
Campelo D; Esteves F; Brito Palma B; Costa Gomes B; Rueff J; Lautier T; Urban P; Truan G; Kranendonk M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563285
[TBL] [Abstract][Full Text] [Related]
10. An electron transfer competent structural ensemble of membrane-bound cytochrome P450 1A1 and cytochrome P450 oxidoreductase.
Mukherjee G; Nandekar PP; Wade RC
Commun Biol; 2021 Jan; 4(1):55. PubMed ID: 33420418
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine is Metabolized by Cytochrome P450 2D6, 3A4, and 2C8, and Inhibits Cytochrome P450 2D6, while its Metabolites also Inhibit Cytochrome P450 3A
Paludetto MN; Kurkela M; Kahma H; Backman JT; Niemi M; Filppula AM
Drug Metab Dispos; 2023 Mar; 51(3):293-305. PubMed ID: 36446607
[TBL] [Abstract][Full Text] [Related]
12. The Role of the FMN-Domain of Human Cytochrome P450 Oxidoreductase in Its Promiscuous Interactions With Structurally Diverse Redox Partners.
Esteves F; Campelo D; Gomes BC; Urban P; Bozonnet S; Lautier T; Rueff J; Truan G; Kranendonk M
Front Pharmacol; 2020; 11():299. PubMed ID: 32256365
[TBL] [Abstract][Full Text] [Related]
13. Human recombinant cytochrome P450 enzymes display distinct hydrogen peroxide generating activities during substrate independent NADPH oxidase reactions.
Mishin V; Heck DE; Laskin DL; Laskin JD
Toxicol Sci; 2014 Oct; 141(2):344-52. PubMed ID: 25061110
[TBL] [Abstract][Full Text] [Related]
14. Human NADPH-P450 oxidoreductase modulates the level of cytochrome P450 CYP2D6 holoprotein via haem oxygenase-dependent and -independent pathways.
Ding S; Yao D; Deeni YY; Burchell B; Wolf CR; Friedberg T
Biochem J; 2001 Jun; 356(Pt 2):613-9. PubMed ID: 11368792
[TBL] [Abstract][Full Text] [Related]
15. Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites.
Sutton D; Butler AM; Nadin L; Murray M
J Pharmacol Exp Ther; 1997 Jul; 282(1):294-300. PubMed ID: 9223567
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a yeast system that stably expresses human cytochrome P450 reductase: application for the study of drug metabolism of cytochrome P450s in vitro.
Cheng J; Wan DF; Gu JR; Gong Y; Yang SL; Hao DC; Yang L
Protein Expr Purif; 2006 Jun; 47(2):467-76. PubMed ID: 16434211
[TBL] [Abstract][Full Text] [Related]
17. Ferrous and ferric state of cytochromes P450 in intact Escherichia coli cells: a possible role of cytochrome P450-flavodoxin interactions.
Culka M; Milichovsky J; Jerabek P; Stiborova M; Martinek V
Neuro Endocrinol Lett; 2015; 36 Suppl 1():29-37. PubMed ID: 26757119
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of CPR from various origins enhances biotransformation activity of human CYPs in S. pombe.
Neunzig I; Widjaja M; Peters FT; Maurer HH; Hehn A; Bourgaud F; Bureik M
Appl Biochem Biotechnol; 2013 Aug; 170(7):1751-66. PubMed ID: 23737303
[TBL] [Abstract][Full Text] [Related]
19. Use of V79 cells with stably transfected cytochrome P450 cDNAs in studying the metabolism and effects of cytotoxic drugs.
Philip PA; Ali-Sadat S; Doehmer J; Kocarek T; Akhtar A; Lu H; Chan KK
Cancer Chemother Pharmacol; 1999; 43(1):59-67. PubMed ID: 9923542
[TBL] [Abstract][Full Text] [Related]
20. CYP3A4 overexpression enhances the cytotoxicity of the antitumor triazoloacridinone derivative C-1305 in CHO cells.
Augustin E; Borowa-Mazgaj B; Kikulska A; Kordalewska M; Pawłowska M
Acta Pharmacol Sin; 2013 Jan; 34(1):146-56. PubMed ID: 23160340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]